The FN1 (fibronectin) exosomal protein, known to be widely expressed in different tumor cells, may serve as a potential diagnostic marker in NSCLC LC diagnosis based on the proteomic analysis of patients with confirmed LC [131]. This evidence concerns the gene FN1 and laryngotracheoesophageal cleft.